DigestRedComo funciona
Red
/
Empresas
De
No verificado

DelveInsight Business Research, LLP

Sobre qué escribimos

BiologíaCienciaEconomíaFarmacéuticaSanidad

202 Comunicados de prensa

Ver todos los comunicados de prensa
17/04/2025
Farmacéutica
Sanidad
Biología
FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
17/04/2025
Farmacéutica
Sanidad
Biología
TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
16/04/2025
Farmacéutica
Sanidad
Biología
ANGPTL3 Inhibitor Market Set for Robust Growth During the Forecast Period (2025-2034) Across 7MM Owing to the Rising Demand for Novel Lipid-Lowering Therapies | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
15/04/2025
Farmacéutica
Sanidad
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
14/04/2025
Farmacéutica
Sanidad
FDA Approval of Amgen's UPLIZNA for IgG4-related Disease Opens New Market Opportunity in Rare Autoimmune Segment | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
09/04/2025
Farmacéutica
Sanidad
Merkel Cell Carcinoma Market to Grow Rapidly at a CAGR of 8.7% During the Study Period (2020-2034) | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
08/04/2025
Farmacéutica
Sanidad
Biología
TIBSOVO's Continued Success Solidifies Its Position as a Leader in IDH1 Mutant Space | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
07/04/2025
Farmacéutica
Sanidad
Biología
Regulatory T-cells (Tregs) Market to Observe Significant Growth by 2034 Owing to the Development in 12+ Indications with Severe and Refractory Patients as the Treatment Addressable Population | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
27/03/2025
Farmacéutica
Sanidad
Biología
The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion Proteins, Monoclonal antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Disorders, and Oncology | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0
26/03/2025
Farmacéutica
Sanidad
VUITY Reports Strong Market Performance, Setting New Benchmark in Presbyopia Care | DelveInsight
Fuente
DelveInsight Business Research, LLP
Editor
PR News Wire
1,00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0